Literature DB >> 34050595

Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashion.

Ryoichi Maenosono1,2, Yeqi Nian1,3, Jasper Iske1,4, Yang Liu1,5, Koichiro Minami1,2, Tabea Rommel6, Friederike Martin7, Reza Abdi8, Haruhito Azuma2, Bernhard A Rosner9, Hao Zhou1, Edgar Milford8, Abdallah Elkhal1, Stefan G Tullius1.   

Abstract

Sex-specific influences have been shown for a variety of diseases. Whether donor or recipient sex and sex hormone levels impact alloimmune responses remains unclear. In unifactorial and multifactorial analyses of more than 400 000 SRTR listed kidney transplant patients, we found that younger female recipients had an inferior death-censored graft survival that was independent of donor sex. In contrast, graft survival was superior in older female recipients, suggesting the impact of recipient sex hormones over chromosomal sex mismatches. Those clinical changes were delineated in experimental skin and heart transplant models showing a prolongation of graft survival in ovariectomized young female recipients. In contrast, graft survival was comparable in ovariectomized and naïve old female recipients. Young ovariectomized mice showed reduced amounts and a compromised T cell proliferation. Deprivation of female hormones dampened the production of interferon (IFN)-γ and interleukin (IL)-17+ by CD4+ T cells while augmenting systemic counts of Tregs. Increasing estradiol concentrations in vitro promoted the switch of naïve CD4+ T cells into Th1 cells; high physiological estradiol concentrations dampening Th1 responses, promoted Tregs, and prolonged graft survival. Thus, clinical observations demonstrate age-specific graft survival patterns in female recipients. Estrogen levels, in turn, impact the fate of T cell subsets, providing relevant and novel information on age- and sex-specific alloimmunity.
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  basic (laboratory) research/science; endocrinology/diabetology; gender; kidney failure/injury; kidney transplantation/nephrology; organ allocation; organ transplantation in general; rejection: T cell mediated (TCMR); reproductive biology

Mesh:

Substances:

Year:  2021        PMID: 34050595      PMCID: PMC8924905          DOI: 10.1111/ajt.16611

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   9.369


  64 in total

1.  Rapamycin Prolongs Graft Survival and Induces CD4+IFN-γ+IL-10+ Regulatory Type 1 Cells in Old Recipient Mice.

Authors:  Markus Quante; Timm Heinbokel; Karoline Edtinger; Koichiro Minami; Hirofumi Uehara; Yeqi Nian; Haruhito Azuma; Reza Abdi; Abdallah Elkhal; Stefan G Tullius
Journal:  Transplantation       Date:  2018-01       Impact factor: 4.939

2.  Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors.

Authors:  Vladislava Paharkova-Vatchkova; Ruben Maldonado; Susan Kovats
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

Review 3.  Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production.

Authors:  Mohamed Labib Salem
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2004-03

4.  Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus.

Authors:  F Krenzien; M Quante; T Heinbokel; M Seyda; K Minami; H Uehara; H R C Biefer; J M Schuitenmaker; S Gabardi; K Splith; M Schmelzle; A K Petrides; H Azuma; J Pratschke; X C Li; A ElKhal; S G Tullius
Journal:  Am J Transplant       Date:  2016-11-21       Impact factor: 8.086

5.  Donor-recipient sex mismatch in kidney transplantation.

Authors:  Jane C Tan; Jane P Kim; Glenn M Chertow; F Carl Grumet; Manisha Desai
Journal:  Gend Med       Date:  2012-08-18

6.  Hormonal profiles after the menopause.

Authors:  S Chakravarti; W P Collins; J D Forecast; J R Newton; D H Oram; J W Studd
Journal:  Br Med J       Date:  1976-10-02

7.  17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells.

Authors:  Asa K Bengtsson; Elizabeth J Ryan; Daniela Giordano; Dario M Magaletti; Edward A Clark
Journal:  Blood       Date:  2004-05-13       Impact factor: 22.113

8.  Sex differences in mortality following acute coronary syndromes.

Authors:  Jeffrey S Berger; Laine Elliott; Dianne Gallup; Matthew Roe; Christopher B Granger; Paul W Armstrong; R John Simes; Harvey D White; Frans Van de Werf; Eric J Topol; Judith S Hochman; L Kristin Newby; Robert A Harrington; Robert M Califf; Richard C Becker; Pamela S Douglas
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

9.  Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.

Authors:  E Goulmy; R Schipper; J Pool; E Blokland; J H Falkenburg; J Vossen; A Gratwohl; G B Vogelsang; H C van Houwelingen; J J van Rood
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

10.  The enhancement effect of estradiol on contextual fear conditioning in female mice.

Authors:  Yui K Matsumoto; Masanori Kasai; Kazuya Tomihara
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

View more
  3 in total

1.  Transition of young adult kidney transplant recipients.

Authors:  Mina Matsuda-Abedini; Stephen D Marks; Bethany J Foster
Journal:  Pediatr Nephrol       Date:  2022-04-30       Impact factor: 3.714

2.  Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation.

Authors:  Yuan Chang; Xiangjie Li; Qi Cheng; Yiqing Hu; Xiao Chen; Xiumeng Hua; Xuexin Fan; Menghao Tao; Jiangping Song; Shengshou Hu
Journal:  Basic Res Cardiol       Date:  2021-12-06       Impact factor: 17.165

3.  From the Cradle to the Grave: The Life Cycle of Gender Disparities in Kidney Care.

Authors:  Rowena Lalji; Roslyn B Mannon
Journal:  Kidney Int Rep       Date:  2022-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.